1. |
邵海琳. 糖尿病视网膜病变的早期防治[J]. 开卷有益(求医问药), 2023, 21(11): 18.Shao HL. Early prevention and treatment of diabetic retinopathy[J]. Journal for Beneficial Readings Drug Information & Medical Advices, 2023, 21(11): 18.
|
2. |
中华医学会眼科学分会眼底病学组, 中国医师协会眼科医师分会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2022年)[J]. 中华眼底病杂志, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.Fundus Pathology Group, Ophthalmology Branch, Chinese Medical Association, Ophthalmology Branch, Chinese Medical Doctor Association. Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)[J]. Chin J Ocul Fundus Dis, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.
|
3. |
中国研究型医院学会糖尿病学专业委员会. 社区医疗机构糖尿病视网膜病变筛查工作流程与管理规范的专家共识(2023版)[J]. 中华糖尿病杂志, 2024, 16(1): 20-27. DOI: 10.3760/cma.j.cn115791-20231010-00229.Diabetology Committee of Chinese Society of Research Hospitals. Expert consensus on workflow and management of screening for diabetic retinopathy in primary healthcare institutions (2023 edition)[J]. Chin J Diabetes Mellitus, 2024, 16(1): 20-27. DOI: 10.3760/cma.j.cn115791-20231010-00229.
|
4. |
中国医师协会内分泌代谢科医师分会, 国家代谢性疾病临床医学研究中心. 糖尿病分型诊断中国专家共识[J]. 中华糖尿病杂志, 2022, 14(2): 120-139. DOI: 10.3760/cma.j.cn115791-20211219-00672.Branch of Endocrinology and Metabolism, Chinese Medical Doctor Association, National Clinical Medical Research Center for Metabolic Diseases. Classification of diabetes mellitus in China: an expert consensus statement[J]. Chin J Diabetes Mellitus, 2022, 14(2): 120-139. DOI: 10.3760/cma.j.cn115791-20211219-00672.
|
5. |
Flaxel CJ, Adelman RA, Bailey ST, et al. Diabetic retinopathy preferred practice pattern®[J]. Ophthalmology, 2020, 127(1): 66-145. DOI: 10.1016/j.ophtha.2019.09.025.
|
6. |
Bourne RRA, Flaxman SR, Braithwaite T, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis[J/OL]. Lancet Glob Health, 2017, 5(9): e888-e897[2017-08-02]. https://pubmed.ncbi.nlm.nih.gov/28779882/. DOI: 10.1016/s2214-109x(17)30293-0.
|
7. |
王文. 对2009年基层版《中国高血压防治指南》的解读[J]. 内科急危重症杂志, 2010, 16(3): 116-119. DOI: 10.3969/j.issn.1007-1024.2010.03.002.Wang W. Interpretation for basic level edition of China guideline for prevention and treatment of hypertension 2009[J]. Journal of Internal Intensive Medicine, 2010, 16(3): 116-119. DOI: 10.3969/j.issn.1007-1024.2010.03.002.
|
8. |
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies[J]. Lancet, 2004, 363(9403): 157-163. DOI: 10.1016/s0140-6736(03)15268-3.
|
9. |
洪豆豆, 权金星, 田利民, 等. 甘肃省平原风沙与黄土丘陵地区糖尿病视网膜病变患病率调查[J]. 中国糖尿病杂志, 2023, 31(10): 721-725. DOI: 10.3969/j.issn.1006-6187.2023.10.001.Hong DD, Kwon JX, Tian LM, et al. Epidemiological investigation and analysis of diabetic retinopathy in windy desert area and loess hilly area of Gansu Province[J]. Chin J Diabetes, 2023, 31(10): 721-725. DOI: 10.3969/j.issn.1006-6187.2023.10.001.
|
10. |
廖季云, 程时富, 查蕾蕾, 等. 阆中市农村地区2型糖尿病视网膜病变的流行特征及危险因素分析[J]. 解放军预防医学杂志, 2020, 38(9): 114-116.Liao JY, Cheng SF, Zha LL, et al. Epidemic characteristics and risk factors of type 2 diabetic retinopathy in rural area of Langzhong city[J]. J Prev Med Chin PLA, 2020, 38(9): 114-116.
|
11. |
高胡进, 覃小芳. Ⅱ型糖尿病性视网膜病变患者不良生活方式调查及其对发病率的影响研究[J]. 实用防盲技术, 2022, 17(2): 80-82. DOI: 10.3969/j.issn.1673-3835.2022.02.010.Gao HJ, Qin XF. Investigation of unhealthy lifestyle and its impact on incidence rate of type Ⅱ diabetic retinopathy[J]. Journal of Practical Preventing Blind, 2022, 17(2): 80-82. DOI: 10.3969/j.issn.1673-3835.2022.02.010.
|
12. |
陈雪珍, 吴慧华, 刘媛媛, 等. 糖尿病视网膜病变患病率的meta分析[J]. 中国公共卫生管理, 2020, 36(4): 460-465. DOI: 10.19568/j.cnki.23-1318.2020.04.006.Chen XZ, Wu HH, Liu YY, et al. A meta-analysis of prevalence rate of diabetic retinopathy[J]. Chinese Journal of Public Health Management, 2020, 36(4): 460-465. DOI: 10.19568/j.cnki.23-1318.2020.04.006.
|
13. |
黄晓波, 张培, 林森林, 等. 2016-2018年上海市新泾社区糖尿病眼病干预效果分析[J]. 中华预防医学杂志, 2022, 56(1): 44-48. DOI: 10.3760/cma.j.cn112150-20211128-01094.Huang XB, Zhang P, Lin SL, et al. Analysis of community intervention effects for diabetic eye diseases in Shanghai Xinjing community from 2016 to 2018[J]. Chin J Prev Med, 2022, 56(1): 44-48. DOI: 10.3760/cma.j.cn112150-20211128-01094.
|
14. |
彭慧, 杨飞飞, 薛俊磊, 等. 上海市嘉定区2型糖尿病患者视网膜病变筛查结果分析[J]. 中国初级卫生保健, 2024, 38(4): 40-43. DOI: 10.3969/j.issn.1001-568X.2024.04.0010.Peng H, Yang FF, Xue JL, et al. Analysis of screening results of retinopathy in type 2 diabetic patients in Jiading distinct of Shanghai[J]. Chinese Primary Health Care, 2024, 38(4): 40-43. DOI: 10.3969/j.issn.1001-568X.2024.04.0010.
|
15. |
蔡文瑶, 杨丽辉, 阿米娜. 2型糖尿病患者发生糖尿病视网膜病变的危险因素分析[J]. 西藏医药, 2023, 44(2): 68-70.Cai WY, Yang LH, Amina. Risk factors of diabetic retinopathy in patients with type 2 diabetes mellitus[J]. Tibetan Medical Journal, 2023, 44(2): 68-70.
|
16. |
卢佳琦, 李帅, 马桂巧, 等. 糖尿病视网膜病变相关危险因素分析及预测模型研究[J]. 实用药物与临床, 2023, 26(6): 504-508. DOI: 10.14053/j.cnki.ppcr.202306005.Lu JQ , Li S, Ma GQ, et al. Analysis of risk factors associated with diabetic retinopathy and the study on the model of prediction[J]. Practical Pharmacy And Clinical Remedies, 2023, 26(6): 504-508. DOI: 10.14053/j.cnki.ppcr.202306005.
|
17. |
薛朔, 毛一凡, 王春芳. 糖尿病视网膜病变危险因素的研究进展[J]. 安徽医药, 2023, 27(5): 863-867. DOI: 10.3969/j.issn.1009-6469.2023.05.004.Xue S, Mao YF, Wang CF. Research progress on risk factors of diabetic retinopathy[J]. Anhui Medical and Pharmaceutical Journal, 2023, 27(5): 863-867. DOI: 10.3969/j.issn.1009-6469.2023.05.004.
|
18. |
赖丽平, 刘贺, 黄锡岚, 等. 2型糖尿病患者的糖尿病视网膜病变患病率及危险因素[J]. 广西医学, 2022, 44(4): 370-375. DOI: 10.11675/j.issn.0253-4304.2022.04.03.Lai LP, Liu H, Huang XL, et al. Prevalence rate of and risk factors for diabetic retinopathy in patients with type 2 diabetes mellitus[J]. Guangxi Medical Journal, 2022, 44(4): 370-375. DOI: 10.11675/j.issn.0253-4304.2022.04.03.
|
19. |
Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy[J]. Diabetes Care, 2012, 35(3): 556-564. DOI: 10.2337/dc11-1909.
|
20. |
高玮, 买买提热夏提·玉苏甫, 卡丽比努尔·艾尔肯, 等. 血清微量元素佐助临床特征预测2型糖尿病性视网膜病变发病风险的价值及模型构建[J]. 川北医学院学报, 2022, 37(1): 51-54. DOI: 10.3969/j.issn.1005-3697.2022.01.012.Gao W, Maimaitirexiati·YSF, Karibinur·EIK. Value analysis and model construction of serum trace element assisted clinical features in predicting the risk of type 2 diabetic retinopathy[J]. Journal of North Sichuan Medical College, 2022, 37(1): 51-54. DOI: 10.3969/j.issn.1005-3697.2022.01.012.
|
21. |
万文萃, 龙洋. 糖尿病视网膜病变的流行病学、病因学与发病机制研究现状[J]. 眼科新进展, 2022, 42(9): 673-679. DOI: 10.13389/j.cnki.rao.2022.0138.Wan WC, Long Y. Research status of epidemiology, etiology and pathogenesis of diabetic retinopathy[J]. Rec Adv Ophthalmol, 2022, 42(9): 673-679. DOI: 10.13389/j.cnki.rao.2022.0138.
|
22. |
肖子轩, 白桂荣, 贺艳婷, 等. 宁夏社区2型糖尿病患者血脂异常情况及影响因素分析[J]. 中国慢性病预防与控制, 2021, 29(5): 382-386. DOI: 10.16386/j.cjpccd.issn.1004-6194.2021.05.014.Xiao ZX, Bai GR, He YT, et al. Analysis of dyslipidemia and its influencing factors in type 2 diabetes patients in Ningxia community[J]. Chinese Journal of Prevention and Control of Chronic Diseases, 2021, 29(5): 382-386. DOI: 10.16386/j.cjpccd.issn.1004-6194.2021.05.014.
|
23. |
龚莹莹, 刘青, 邱威, 等. 糖尿病患者视网膜病变危险因素分析及其对眼前段生物学结构的影响[J]. 国际眼科杂志, 2020, 20(7): 1216-1221. DOI: 10.3980/j.issn.1672-5123.2020.7.22.Gong YY, Liu Q, Qiu W, et al. Analysis of the related risk factors of diabetic retinopathy and changes of biological structures of anterior segment in diabetic patients[J]. Int Eye Sci, 2020, 20(7): 1216-1221. DOI: 10.3980/j.issn.1672-5123.2020.7.22.
|
24. |
王金瑞, 杨莹. 2型糖尿病视网膜病变相关因素研究进展[J]. 昆明医科大学学报, 2019, 40(4): 131-135. DOI: 10.3969/j.issn.1003-4706.2019.04.027.Wang JR, Yang Y. Research progress of related factors of type 2 diabetic retinopathy[J]. Journal of Kunming Medical University, 2019, 40(4): 131-135. DOI: 10.3969/j.issn.1003-4706.2019.04.027.
|
25. |
李莹, 董哲毅, 王倩, 等. 2型糖尿病合并不同病理分型肾病的眼底表现[J]. 解放军医学院学报, 2022, 43(10): 1031-1035. DOI: 10.3969/j.issn.2095-5227.2022.10.006.Li Y, Dong ZY, Wang Q, et al. Fundus manifestations of different types of nephropathy in type 2 diabetes mellitu[J]. Acad J Chin PLA Med Sch, 2022, 43(10): 1031-1035. DOI: 10.3969/j.issn.2095-5227.2022.10.006.
|
26. |
Sabanayagam C, Sultana R, Banu R, et al. Association between body mass index and diabetic retinopathy in Asians: the Asian Eye Epidemiology Consortium (AEEC) study[J]. Br J Ophthalmol, 2022, 106(7): 980-986. DOI: 10.1136/bjophthalmol-2020-318208.
|